devAIce is an AI-powered audio analysis platform that detects vocal biomarkers and emotional expression from speech for clinical assessment and patient monitoring. Available as SDK, Web API, and XR plug-in, it analyzes approximately 7,000 acoustic parameters to identify disease-specific vocal marker...
Manufactured by
audEERING GmbH
Germany
audEERING® is a pioneer in speech and acoustic AI, enabling machines to interpret the human voice as a meaningful signal of expression, affect, cognition, and health-related states. Based on deep foundation models for speech AI, audEERING® converts vocal signals into reliable, scientifically grounded insights.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
a.cure
South Korea · 3 relevant products
FaceHeart Inc.
Taiwan · 1 relevant product
SLOWAVE INC.
South Korea · 1 relevant product
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →18 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 81 closest product alternatives
a.cure · South Korea
Proprietary software that processes voice samples to extract biomarkers indicative of cardiovascular disease severity and progression. The technology enables non-invasive health risk stratification through acoustic analysis of patient voice patterns.
FaceHeart Inc. · Taiwan
Proprietary software utilizing facial video to extract physiological parameters through artificial intelligence. Designed for integration into medical and diagnostic workflows.
a.cure · South Korea
“Heart to Voice” is an AI model that evaluates heart failure severity by analyzing voice data and clinical indicators, supporting patient care from high-risk screening to post-discharge management. a.cure is developing a prescription-based voice monitoring solution for discharged heart failure patients. Through once-daily voice monitoring, the system analyzes condition changes and detects early signs of deterioration, enabling timely intervention and helping prevent hospital readmission. The AI model provides a four-level severity classification based on voice recordings of about 10 seconds, with a target performance of AUC 95%. Using a non-invasive voice analysis approach, the solution allows convenient use in everyday environments and continuous monitoring after discharge. A web-based dashboard and notification system enable healthcare providers and caregivers to monitor patient status and provide lifestyle guidance based on severity levels.
78 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products